Followers | 44 |
Posts | 2710 |
Boards Moderated | 0 |
Alias Born | 03/11/2014 |
Wednesday, November 18, 2020 10:23:25 AM
Todos is evaluating the best option for the commercialization of its rapid POC version of the 3CL protease assay for the screening & diagnosis of symptomatic & asymptomatic COVID-19 carriers, based on recent updated guidance from the FDA. https://t.co/fmEJGK2i1Q $TOMDF
— Todos Medical (@todosmedical) November 18, 2020
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM